PolyPeptide Group AG
SIX:PPGN
Relative Value
The Relative Value of one
PPGN
stock under the Base Case scenario is
hidden
CHF.
Compared to the current market price of 23.95 CHF,
PolyPeptide Group AG
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PPGN Competitors Multiples
PolyPeptide Group AG Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CH |
|
PolyPeptide Group AG
SIX:PPGN
|
790.1m CHF | 2.4 | -25.1 | 33.3 | -105.1 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1T USD | 364 | 4 310.7 | 1 235.1 | 2 378.3 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
188.7B USD | 4.2 | 28.2 | 19.7 | 26.5 | |
| US |
|
Danaher Corp
NYSE:DHR
|
138.6B USD | 5.6 | 38.3 | 19.5 | 28.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
82.3T KRW | 18.1 | 46.1 | 30.1 | 39.4 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
34.8B CHF | 5.3 | 36.8 | 27.3 | 27.3 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
267.7B CNY | 6 | 17.9 | 17.9 | 17.9 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
32.7B USD | 4.6 | 25.3 | 19.9 | 23.8 | |
| US |
|
Waters Corp
NYSE:WAT
|
30B USD | 9.4 | 46.5 | 30 | 37.8 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
29.8B USD | 1.8 | 22 | 12.1 | 18.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
24.8B USD | 6.2 | 28.5 | 21.2 | 23.6 |